Production (Stage)
Ikena Oncology, Inc.
IKNA
$1.43
$0.064.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 67.90% | 5.53% | 10.85% | 25.46% | 14.96% |
| Total Depreciation and Amortization | 0.00% | -2.25% | -1.11% | -2.17% | -57.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.29% | 0.24% | -2.52% | -3.57% | -54.49% |
| Change in Net Operating Assets | 48.21% | -312.82% | 2,501.56% | 64.64% | 96.57% |
| Cash from Operations | 67.60% | -68.72% | 29.96% | 28.51% | 31.70% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | 2.70% | 208.33% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 214.54% | 1,613.17% | -95.00% | 148.17% | 107.65% |
| Cash from Investing | 214.54% | 1,613.17% | -95.10% | 141.30% | 108.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 918.52% | 54.63% | -1,223.45% | 106.01% | 87.20% |